Visual Outcomes of Functional Intraocular Lenses in Cataracts
Visual Outcomes of Different Types of Functional Intraocular Lenses in Cataract Patients
1 other identifier
observational
20,000
0 countries
N/A
Brief Summary
This is a prospective, multi-center, randomized comparative study. The purpose of the study is to evaluate and compare the objective and subjective visual outcomes of different types of functional intraocular lenses (IOLs) in patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2023
CompletedFirst Posted
Study publicly available on registry
October 23, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2031
October 23, 2023
October 1, 2023
6.1 years
October 15, 2023
October 19, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
uncorrected distance visual acuity (UDVA)
uncorrected visual acuity at 5 m
one year
best corrected distance visual acuity (BCVA)
corrected visual acuity at 5 m
one year
uncorrected near visual acuity (UNVA)
uncorrected visual acuity at 40 cm
one year
uncorrected intermediate visual acuity (UIVA)
uncorrected visual acuity at 60 cm
one year
Secondary Outcomes (8)
HOAs
three months
Strehl Ratio
three months
objective visual quality
three months
contrast sensitivity
three months
visual functions
three months
- +3 more secondary outcomes
Eligibility Criteria
Catarct
You may qualify if:
- cataract
- age \> 18 years
You may not qualify if:
- amblyopia; previous ocular surgery;
- ocular pathologies such as diabetic retinopathy, macular degeneration, glaucoma with field defects;
- requirements for further ocular surgery (other than Nd:YAG capsulotomy) or retinal laser treatments during the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jin Yang
Department of Ophthalmology, Eye and Ear, Nose, and Throat Hospital, Fudan University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 15, 2023
First Posted
October 23, 2023
Study Start
December 1, 2023
Primary Completion (Estimated)
December 30, 2029
Study Completion (Estimated)
December 30, 2031
Last Updated
October 23, 2023
Record last verified: 2023-10